Yungjin Pharm. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jun '26 Jun 15, 2026	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Market Capitalization	235,017	287,744	348,135	150,622	145,500	92,268
Market Cap Growth	-41.06%	-17.35%	131.13%	3.52%	57.69%	-33.17%
Enterprise Value	-	311,216	366,840	163,118	185,784	128,217
Last Close Price	1285.00	1620.00	1960.00	848.00	1091.83	692.38
PE Ratio	24.02	160.37	134.89	-	-	-
PS Ratio	1.48	2.09	3.11	1.30	1.41	0.83
PB Ratio	2.37	3.16	3.87	1.64	2.39	1.44
P/TBV Ratio	2.46	3.30	4.03	1.70	2.54	1.52
P/FCF Ratio	196.87	-	-	-	-	19.00
P/OCF Ratio	37.39	120.94	40.97	-	-	8.95
EV/Sales Ratio	-	2.26	3.27	1.40	1.80	1.16
EV/EBITDA Ratio	-	39.42	45.53	39.06	66.49	33.33
EV/EBIT Ratio	-	95.24	89.79	403.32	-	313.92
EV/FCF Ratio	-	-	-	-	-	26.40
Debt / Equity Ratio	0.28	0.27	0.31	0.35	0.77	0.63
Debt / EBITDA Ratio	1.94	3.16	3.46	7.68	16.85	10.47
Debt / FCF Ratio	23.51	-	-	-	-	8.30
Net Debt / Equity Ratio	0.24	0.24	0.24	0.14	0.76	0.61
Net Debt / EBITDA Ratio	1.62	2.82	2.63	2.99	16.56	10.19
Net Debt / FCF Ratio	19.64	-29.01	-3.98	-	-12.70	8.07
Asset Turnover	0.94	0.86	-	-	0.74	0.89
Inventory Turnover	3.12	3.27	-	-	2.77	3.09
Quick Ratio	1.20	1.18	1.18	-	0.66	0.75
Current Ratio	2.06	1.95	1.86	-	1.44	1.48
Return on Equity (ROE)	9.00%	1.98%	2.84%	-3.02%	-6.96%	-10.51%
Return on Assets (ROA)	3.63%	1.28%	-	-	-0.29%	0.20%
Return on Invested Capital (ROIC)	7.31%	2.01%	3.06%	0.38%	-0.61%	0.43%
Return on Capital Employed (ROCE)	7.40%	2.60%	3.40%	-	-0.80%	0.50%
Earnings Yield	3.63%	0.62%	0.74%	-1.53%	-2.99%	-6.34%
FCF Yield	0.51%	-0.27%	-1.53%	-	-2.50%	5.26%
Buyback Yield / Dilution	14.83%	-4.28%	-	-	-	-19.10%